Investigators note that although the overall cost for implementing next-generation sequencing (NGS) testing would be more than implementing current polymerase chain reaction (PCR)–based testing, the ...
New Working Group to Evaluate Clinical Utility of NGS-Based Testing to Inform Coverage After many years of steady development in DNA sequencing, the scientific community is reaching an exciting ...
LONDON and CARLSBAD, Calif., Nov. 5, 2025 /PRNewswire/ -- DNAe, the Next-Generation Sequencing (NGS) company developing a transformative fully automated, sample-to-report diagnostics platform, today ...
CARLSBAD, Calif., Jan. 26, 2024 /PRNewswire/ -- ChromaCode, Inc., a pioneering genomics multiplexing platform company developing accessible and affordable laboratory-based solutions, today announced ...
The Miro Canvas is a new platform which enables full walkaway automation of complex next generation sequencing (NGS) sample prep protocols. The system uses novel digital microfluidic technology to ...
Both the use of next-generation sequencing (NGS) testing for cancer and the rate of claim denials for such testing increased between 2016 and 2021, despite implementation of a recent Medicare national ...
Collaboration integrates per-sample NGS internal standards with multi-omic precision oncology platform to enhance cancer diagnostics accuracy and access The Accukit™ CRC/NSCLC Internal Standards are ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback